# A RCT COMPARING LACTULOSE AND RIFAXIMIN ASSOCIATED WITH A VEGETABLE DIET IN THE PREVENTION OF POST-TIPS OVERT HEPATIC ENCEPHALOPATHY

> **NCT02931123** · PHASE1,PHASE2 · UNKNOWN · sponsor: **University of Roma La Sapienza** · enrollment: 58 (estimated)

## Conditions studied

- Cirrhotic Patients Undergoing TIPS Placement

## Interventions

- **DRUG:** lattulose and rifaximine

## Key facts

- **NCT ID:** NCT02931123
- **Lead sponsor:** University of Roma La Sapienza
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-11
- **Primary completion:** 2017-11
- **Final completion:** 2018-11
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2016-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02931123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02931123, "A RCT COMPARING LACTULOSE AND RIFAXIMIN ASSOCIATED WITH A VEGETABLE DIET IN THE PREVENTION OF POST-TIPS OVERT HEPATIC ENCEPHALOPATHY". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT02931123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*